From the Pressroom
Videos from KCA patient and survivor conference that held in North Carolina on December 9th, 2017 is now available online.
FDA Grants Breakthrough Designation for Avelumab in Combination with INLYTA in Advanced Renal Cell Carcinoma
A combination approach with an immunotherapy, whose activity may complement existing agents such as INLYTA, has the potential to improve outcomes for patients with advanced renal cancer…
Submit your press release
We welcome your press release. The Kidney Cancer Association invites organizations and companies with information of interest to kidney cancer patients, survivors, and their families to submit press releases to:
Fax: +1 (847) 332-2978
Submitters are responsible for the content of press releases and publishing by our charity does not imply the endorsement of the Kidney cancer Association or its officers, directors, staff, or members.
- September 22 - September 23
- November 2 - November 3
- November 26 @ 1:00 pm - 3:30 pm